07 Sep, 2025
4 mins read

Sweeteners in diet drinks may steal years from the brain

The study followed 12,772 adults with an average age of 52 Researchers tracked seven artificial sweeteners typically found in ultra-processed foods like flavored water, soda, energy drinks, yogurt and low-calorie desserts People who consumed the highest total amounts of these sweeteners had faster decline in overall thinking and memory skills compared to people who consumed […]

7 mins read

New medication lowers hard-to-control high blood pressure in people with chronic kidney disease

Credit: Pixabay/CC0 Public Domain Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of kidney disease in people with chronic kidney disease and uncontrolled high blood pressure , according to preliminary research presented at the American Heart Association’s Hypertension Scientific Sessions 2025. This study is published […]

5 mins read

Do pediatricians recommend vaccines to make a profit?

Credit: Gustavo Fring from Pexels It makes sense to approach some marketing efforts with skepticism. Scams, deepfakes, and deceptive social media posts are common, with people you don’t know seeking to profit from your behavior. But should people extend this same skepticism to pediatricians who advise vaccines for children? Health and Human Services Secretary Robert […]

2 mins read

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Credit: Pixabay/CC0 Public Domain An analysis from the Phase III CheckMate 77T trial confirms that perioperative nivolumab does not compromise health-related quality of life (HRQoL) in patients with resectable non-small cell lung cancer (NSCLC), including those with Stage III N2 disease. These results were presented at the International Association for the Study of Lung Cancer […]

2 mins read

Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer

Credit: Unsplash/CC0 Public Domain A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a 100% objective response rate (ORR) in patients with first-line EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC). This study was presented at the International Association for the Study of Lung Cancer 2025 World Conference […]